Sandra Sanchez
View from the Top
Sandra Sánchez
Director General
PROBIOMED
Corporate governance strengthens the internal capabilities of PROBIOMED to build partnerships and transforms the organization’s cultural mindset
Laboratorio
Spotlight
Biotechnology represents a promising alternative over chemically synthesized drugs for chronic and degenerative diseases.
MHS 2015
News Article
Mexico Health Summit 2015: Pharmaceuticals, Life Sciences, and Mexico’s New Health Economy Panel highlights
Sandra Sánchez-Oldenhage
View from the Top
Sandra Sánchez-Oldenhage
Director General
PROBIOMED
Today, PROBIOMED is the only company in Mexico that is able to manufacture high-quality products at a low cost.
Subscribe to PROBIOMED